Feasibility of Sildenafil for the Prevention of Right Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation: The REVAD Trial

Can J Cardiol. 2024 Apr;40(4):659-661. doi: 10.1016/j.cjca.2023.11.017. Epub 2023 Nov 22.

¹ Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada. Electronic address: nmfine@ucalgary.ca.
² Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.
³ Division of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.
⁴ Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
⁵ Division of Cardiology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

No abstract available

Publication types